NASDAQFinancialsFinancial - Data & Stock ExchangesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for VALU yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Free cash flow yield stays near 5% | The company generates free cash flow with a yield of 5%. | Under Pressure | Free cash flow yield falls below 5% | Free cash flow yield: 4.25% As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 20264.25 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 21, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a Financials-sector investment with a durable-premium valuation profile, but the evidence does not establish a durable growth record. The long-term thesis is on watch: management is rated stable, while recent financial performance is weak and risk is elevated.
VALU is valued at a 1.68 premium versus peers, with a durable premium identified as the main valuation driver. The expectations gap is 0.44, and priced-in fragility is rated low, so the evidence does not indicate that weak execution is fully reflected in expectations.
Near term, consecutive earnings misses and a 48% estimated miss probability make the next report a key test; the company is also a smaller-cap name, which carries a higher miss base rate. Recent performance sits well below its industry cohort, though it has not freshly broken, and earnings quality is neutral. The valuation measure fell by 11 points, while the January director transition is a recorded negative event; the evidence gives no further detail on its effect.
The multi-year view partly hinges on the rate backdrop: the evidence says rate cuts from the current 3.88% could weigh on Financials, while rates staying high have tended to support the sector. It also hinges on sector signals: continued earnings strength and higher guidance from SPGI, CME, and ICE could sustain a tailwind, while misses or lower guidance could weaken it. For VALU itself, a key swing factor is whether execution improves enough to address its run of misses and weak relative performance.
For the next 1 to 3 years, VALU remains a watch-state thesis with a premium valuation, weak recent performance, and meaningful execution and sector risks. The evidence is medium confidence and does not show that the expectations gap has been resolved. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Maintain profit margins near current levels |
| A primary condition in Value Line, Inc.'s published investment case. The stated target is Maintain profit margin near current TTM levels. |
| Broken |
| Profit margin declines significantly below recent TTM levels |
Net margin: 57.82% FY2027-Q1; GAAP. Published target: Maintain profit margin near current TTM levels. Target percentage unit is not explicit. Sep 14, 202657.818904 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth remains above -5% annually | A primary condition in Value Line, Inc.'s published investment case. The stated target is >= -5% YoY revenue growth. | Intact | YoY revenue growth falls below -5% next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.